These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 27817196)
1. The detection of tumor location and lymph node metastasis by aberrant NXPH1 and NXPH2 expressions in pancreatic ductal adenocarcinomas. Jin JS; Tsai WC Chin J Physiol; 2016 Dec; 59(6):348-354. PubMed ID: 27817196 [TBL] [Abstract][Full Text] [Related]
2. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas. Piao J; Liu S; Xu Y; Wang C; Lin Z; Qin Y; Liu S Exp Mol Pathol; 2015 Feb; 98(1):1-6. PubMed ID: 25445504 [TBL] [Abstract][Full Text] [Related]
3. Comparison of ILK and ERP29 expressions in benign and malignant pancreatic lesions and their clinicopathological significances in pancreatic ductal adenocarcinomas. Zhang K; Yao H; Yang Z; Li D; Yang L; Zou Q; Yuan Y; Miao X Clin Transl Oncol; 2016 Apr; 18(4):352-9. PubMed ID: 26887611 [TBL] [Abstract][Full Text] [Related]
4. The Clinical and Pathological Significance of Nectin-2 and DDX3 Expression in Pancreatic Ductal Adenocarcinomas. Liang S; Yang Z; Li D; Miao X; Yang L; Zou Q; Yuan Y Dis Markers; 2015; 2015():379568. PubMed ID: 26294807 [TBL] [Abstract][Full Text] [Related]
5. Sineoculis homeobox homolog 1 protein overexpression as an independent biomarker for pancreatic ductal adenocarcinoma. Jin A; Xu Y; Liu S; Jin T; Li Z; Jin H; Lin L; Lin Z Exp Mol Pathol; 2014 Feb; 96(1):54-60. PubMed ID: 24263054 [TBL] [Abstract][Full Text] [Related]
6. Glypican-3 and KRT19 are markers associating with metastasis and poor prognosis of pancreatic ductal adenocarcinoma. Yao H; Yang Z; Liu Z; Miao X; Yang L; Li D; Zou Q; Yuan Y Cancer Biomark; 2016; 17(4):397-404. PubMed ID: 27689616 [TBL] [Abstract][Full Text] [Related]
7. [Expression and clinical significance of Tspan 1 and Integrin α6 in human pancreatic ductal adenocarcinoma]. Shi G; Dong M; Sheng W; Zhou J; Yu D; Sun W Zhonghua Wai Ke Za Zhi; 2014 Oct; 52(10):781-6. PubMed ID: 25573220 [TBL] [Abstract][Full Text] [Related]
8. Expression of UGP2 and CFL1 expression levels in benign and malignant pancreatic lesions and their clinicopathological significance. Wang L; Xiong L; Wu Z; Miao X; Liu Z; Li D; Zou Q; Yang Z World J Surg Oncol; 2018 Jan; 16(1):11. PubMed ID: 29347944 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of B2M and loss of ALK7 expression are associated with invasion, metastasis, and poor-prognosis of the pancreatic ductal adenocarcinoma. Liu C; Yang Z; Li D; Liu Z; Miao X; Yang L; Zou Q; Yuan Y Cancer Biomark; 2015; 15(6):735-43. PubMed ID: 26406402 [TBL] [Abstract][Full Text] [Related]
10. HBXIP protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas. Zhou X; Wang X; Duan J; Sun W; Chen Z; Li Q; Ou Z; Jiang G; Ren X; Liu S Pathol Res Pract; 2019 Feb; 215(2):343-346. PubMed ID: 30583814 [TBL] [Abstract][Full Text] [Related]
11. BIRC7 and KLF4 expression in benign and malignant lesions of pancreas and their clinicopathological significance. Yang Z; Li D; Liu Z; Miao X; Yang L; Zou Q; Yuan Y Cancer Biomark; 2016; 17(4):437-444. PubMed ID: 27802195 [TBL] [Abstract][Full Text] [Related]
12. Comparison of morphological features in lymph node metastasis between pancreatic neuroendocrine neoplasms and pancreatic ductal adenocarcinomas. Takahashi D; Kojima M; Morisue R; Sugimoto M; Kobayashi S; Takahashi S; Konishi M; Gotohda N; Ikeda M; Ochiai A Pancreatology; 2020 Jul; 20(5):936-943. PubMed ID: 32553561 [TBL] [Abstract][Full Text] [Related]
13. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma. Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of Mesothelin in Pancreatic Ductal Adenocarcinoma (PDAC). Le K; Wang J; Zhang T; Guo Y; Chang H; Wang S; Zhu B Int J Med Sci; 2020; 17(4):422-427. PubMed ID: 32174772 [No Abstract] [Full Text] [Related]
15. Lack of CCR7 expression is rate limiting for lymphatic spread of pancreatic ductal adenocarcinoma. Sperveslage J; Frank S; Heneweer C; Egberts J; Schniewind B; Buchholz M; Bergmann F; Giese N; Munding J; Hahn SA; Kalthoff H; Klöppel G; Sipos B Int J Cancer; 2012 Aug; 131(4):E371-81. PubMed ID: 22020953 [TBL] [Abstract][Full Text] [Related]
16. Increased expression of valosin-containing protein (p97) is associated with lymph node metastasis and prognosis of pancreatic ductal adenocarcinoma. Yamamoto S; Tomita Y; Hoshida Y; Nagano H; Dono K; Umeshita K; Sakon M; Ishikawa O; Ohigashi H; Nakamori S; Monden M; Aozasa K Ann Surg Oncol; 2004 Feb; 11(2):165-72. PubMed ID: 14761919 [TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer. Von Marschall Z; Scholz A; Stacker SA; Achen MG; Jackson DG; Alves F; Schirner M; Haberey M; Thierauch KH; Wiedenmann B; Rosewicz S Int J Oncol; 2005 Sep; 27(3):669-79. PubMed ID: 16077915 [TBL] [Abstract][Full Text] [Related]
18. Decreased TIP30 expression predicts poor prognosis in pancreatic cancer patients. Guo S; Jing W; Hu X; Zhou X; Liu L; Zhu M; Yin F; Chen R; Zhao J; Guo Y Int J Cancer; 2014 Mar; 134(6):1369-78. PubMed ID: 24037692 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of FZD1 and CAIX are Associated with Invasion, Metastasis, and Poor-Prognosis of the Pancreatic Ductal Adenocarcinoma. Yang L; Yang Z; Li D; Liu Z; Zou Q; Yuan Y; Xu H Pathol Oncol Res; 2018 Oct; 24(4):899-906. PubMed ID: 28921449 [TBL] [Abstract][Full Text] [Related]